Mexico – Diabetes, Peripheral Artery Disease and Critical Limb Ischemia 2014
Research on the epidemiology of peripheral artery disease (PAD) and critical limb ischemia (CLI) in Mexico remains sparse.
Mexico: Diabetes, Peripheral Artery Disease and Critical Limb Ischemia contains a comprehensive analysis of the 2010 prevalence of diabetes, PAD and CLI. The prevalence of PAD and CLI are projected for the 2010-2030 periods.
Prevalence is defined as the number of new and old cases of peripheral artery disease and critical limb ischemia.
Peer-reviewed research on the incidence and prevalence of diabetes, peripheral artery disease and critical limb ischemia in Mexico is reviewed, analyzed and assessed. A discussion of other cardiovascular risk factors is also included. The prevalence of diabetic foot ulcers and ischemic (PAD/CLI) diabetic foot ulcers is estimated for Mexico. The estimated annual number of CLI-related amputations in Mexico is included.
PAD and CLI prevalence is estimated based on The Diabetes Method, which was previously validated in CLI Volume I. The Diabetes Method begins with segmenting the population of each country by age and glucose status, calculating the prevalence of peripheral artery disease in each glucose category and finally the prevalence of critical ischemia by PAD and glucose status.
Epidemiological data on glucose status by age is available for Mexico. A number of recent studies have also been published on prevalence of PAD in various high-risk as well as the general populations in the country. However, none of these examined the detailed prevalence of PAD by age group and glucose status that we needed for our population-based estimates. In the absence of such studies THE SAGE GROUP estimated PAD prevalence based on previous research published in CLI Volumes I and II.
To purchase call us at 404 520-6652 or